Researches

Secondary Solid Cancers in Patients of Hodgkin’s Lymphoma

10.5350/BTDMJB201208203

  • Mustafa Yıldırım
  • Mustafa Yıldız
  • Erdal Kurtoğlu
  • Hülya Karakılınç
  • Sevil Göktaş
  • Mükremin Uysal
  • Betül Çelik

Received Date: 19.12.2011 Accepted Date: 06.04.2012 Med J Bakirkoy 2012;8(2):66-69

Objective:

In this article, we will discuss secondary solid cancers identified in patients diagnosed with Hodgkin’s lymphoma (HL), with the 1996-2008 data of Antalya Cancer Recording Center which gathers population-based data in accordance with the cancer recording standards of World Health Organization’s International Cancer Research Agency.

Material and Methods:

The study included patients that were histopathologically diagnosed with HL from 1996 to 2008. The patients without histopathological diagnosis were not included in the assessment.

Results:

The study covered 320 patients, including 188 (58.8%) males and 132 (41.3%) females. Nine out of 320 patients (2.8%) had developed secondary solid tumors. The most commonly identified tumors were seen in nasopharynx (2 cases) and larynx (1 case), followed by lung and breast with 2 cases for each.

Conclusion:

Although HL can be cured, treatment-related complications prevail. Secondary tumor development, which is one of the complications in such patients, should be carefully monitored.

Keywords: Hodgkin Lymphoma, secondary solid cancers, side effect